eLife collaborates with Novel Coronavirus Research Compendium on manuscript curation and review | For the press | eLife

eLife has announced today its collaboration with the Novel Coronavirus Research Compendium (NCRC), a publicly available resource from Johns Hopkins Bloomberg School of Public Health, US, that rapidly curates and reviews emerging scientific evidence about SARS-CoV-2 and COVID-19.

Following the significant growth in research outputs relating to the COVID-19 pandemic, the need for an efficient system to help readers navigate new results has become clear. Both eLife and the team behind the NCRC have been working separately on solutions that involve bringing expert peer review and curation to new papers. While eLife evaluates preprints in all areas of biology and medicine as part of its Preprint Review service, the NCRC focuses specifically on SARS-CoV-2 and COVID-19 research published either as preprints or in scientific journals. The faculty, fellows, alumni and students behind the Compendium select research for public health action and assign teams of experts to review and summarise the key findings of the papers.

eLife is now working with the NCRC to integrate the Compendium into Sciety, a new platform developed by a team within eLife.